{
  "insp_id": "2016082568870506",
  "layout": "a",
  "customer_id": "1761",
  "customer_name": "Comparative Biosciences, Inc.",
  "customer_addr": "786 Lucerne Drive\nSunnyvale, CA 94085",
  "certificate": "93-R-0398",
  "site_id": "003",
  "site_name": "COMPARATIVE BIOSCIENCES, INC.",
  "insp_type": "ROUTINE INSPECTION",
  "date": "19-AUG-2016",
  "report_date": "24-JAN-2018",
  "citations": [
    {
      "code": "2.31(d)(1)(iv)(A)",
      "kind": "",
      "repeat": false,
      "desc": "INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC).",
      "narrative": "Approved proposal CB-I-9232 involving guinea pigs is a Category E study that states \u201cThe endpoint of this study is\ndeath.\u201d However, the section under \u201cJustification for Classification E\u201d is left blank. The IACUC approved the\nproposal \u201c\u2026 for one experiment only\u201d (one subgroup of animals), and had subsequently decided not to continue\nwith this type of experiment for welfare reasons.\nCategory E studies are those where measures that would commonly be undertaken to minimize pain and distress,\nsuch as administering analgesics, cannot be undertaken because they would interfere with the goals of the study,\nand these studies must include a scientific justification. Without an explanation as to why pain medications cannot\nbe administered, the proposal should not be approved. The IACUC must ensure that the investigator has carefully\nconsidered all possible means to minimize any possible pain and/or distress.\nSteps should be undertaken immediately to ensure that no animals unnecessarily forego standard treatments to\nminimize pain and distress. No activities that might cause pain or distress in Category E studies should be\nconducted until the IACUC reviews such scientific justifications and approves such activities.\nCorrection date: The noncompliance cited above should be corrected for all future proposals."
    },
    {
      "code": "2.31(d)(1)",
      "kind": "",
      "repeat": false,
      "desc": "INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC).",
      "narrative": "The proposal CB-I-9246 involves collection of bone marrow specimens in pigs. Bone marrow was collected from\none animal on February 11, 2016. The Attending Veterinarian certified their involvement in the planning of the\nproposed activity on February 3, 2016. The IACUC members received the proposal and approved designated\nmember review on or about February 3, 2016. However, the Designated Member did not complete review and the\nproposal was not approved by the IACUC until February 26, 2016. Therefore, procedures were completed on one\nanimal prior to approval by the IACUC.\nThe IACUC must ensure that no proposed activities are initiated until after complete IACUC review and approval.\nInitiation of any procedure prior to approval precludes the IACUC from performing review and assurances under\n2.31 (d) such as related to minimization of pain or distress, consideration of alternatives, that activities do not\nunnecessarily duplicate previous experiments, the complete description of activities and the rationale for using\nanimals. Therefore, lack of prospective review and approval precludes the IACUC members to fulfill their function of\nsafeguarding the welfare of the animals.\nThe IACUC must assure that no proposal-related activities occur prior to IACUC approval.\nCorrection date: From this date forward."
    },
    {
      "code": "2.31(e)(3)",
      "kind": "",
      "repeat": false,
      "desc": "INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC).",
      "narrative": "The proposal CB-I-9234 that involves guinea pigs states \u201cHistology is generally performed\u2026 biopsies\u2026 may be\ncollected by procedures from which the animals are allowed to recover. Other tissues will be removed under\nanesthesia as terminal procedures.\u201d However, under the Surgery section of the proposal it states \u201cSurgical\nProcedures \u2013 None\u201d and under \u201cSurgery\u201d it states \u201cNot Applicable.\u201d There is no description of the biopsy or terminal\nprocedures in the version of the proposal approved by the Institutional Animal Care and Use Committee (IACUC).\nThe proposal CB-I-9218 that involves pigs states \u201cBlood samples will be collected\u2026 via either surgically implanted\ncatheter or direct venipuncture.\u201d However, under the \u201cSurgery\u201d section of the proposal it states \u201cNot Applicable.\u201d\nThere is no description of the surgical implantation procedures in the version of the proposal approved by the\nInstitutional Animal Care and Use Committee (IACUC).\nThe IACUC must ensure that the investigator has provided a complete description of all procedures to be performed\non the animals. Without a complete description, the IACUC members are not able to consider possible alternatives\nthat might minimize pain and distress for the animals, to examine and ask questions about procedures and the\neffects on the animals. Therefore, such omission of these details precludes the IACUC members to fulfill their\nfunction of safeguarding the welfare of the animals.\nCorrection date: To be corrected in all approved proposals by 11/20/16 and from this date forward for new\nproposals."
    },
    {
      "code": "2.31(e)(4)",
      "kind": "",
      "repeat": false,
      "desc": "INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC).",
      "narrative": "Approved proposal CB-I-9242 involving rabbits is a Category E study. The proposal form includes a section for\n\u201cOther potential stressors and procedures to monitor and minimize distress,\" and the investigator states: \u201cRabbits\nshowing indication of pain or distress may be administered any of the following as relevant: systemic analgesics\n(eg: buprenorphine); topical local anesthetics.\u201d Later in the \u201cJustification for Classification E\u201d section the investigator\nstates: \u201c\u2026 in most studies some toxicity will be intentionally produced and there may be attendant pain and/or\ndistress, and even mortality. In general it is assumed that pain-relieving drugs may interfere with the toxicity to be\nobserved, and such drugs are withheld.\u201d It is not clear whether there is any reason why these animals cannot\nreceive pain medications.\nCategory E studies are those where measures that would commonly be undertaken to minimize pain and distress,\nsuch as administering analgesics, cannot be undertaken because they would interfere with the goals of the study,\nand these studies must include a scientific justification. Without an explanation as to why pain medications cannot\nbe administered, the proposal should not be approved.\nCorrection date: The noncompliance cited above should be corrected for all future proposals.\nThis inspection and exit briefing were conducted with facility representatives.\nAdditional Inspectors\nSmith Pamela, Veterinary Medical Officer"
    }
  ],
  "narrative": "2.31(d)(1)(iv)(A)\nINSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC).\nApproved proposal CB-I-9232 involving guinea pigs is a Category E study that states \u201cThe endpoint of this study is\ndeath.\u201d However, the section under \u201cJustification for Classification E\u201d is left blank. The IACUC approved the\nproposal \u201c\u2026 for one experiment only\u201d (one subgroup of animals), and had subsequently decided not to continue\nwith this type of experiment for welfare reasons.\nCategory E studies are those where measures that would commonly be undertaken to minimize pain and distress,\nsuch as administering analgesics, cannot be undertaken because they would interfere with the goals of the study,\nand these studies must include a scientific justification. Without an explanation as to why pain medications cannot\nbe administered, the proposal should not be approved. The IACUC must ensure that the investigator has carefully\nconsidered all possible means to minimize any possible pain and/or distress.\nSteps should be undertaken immediately to ensure that no animals unnecessarily forego standard treatments to\nminimize pain and distress. No activities that might cause pain or distress in Category E studies should be\nconducted until the IACUC reviews such scientific justifications and approves such activities.\nCorrection date: The noncompliance cited above should be corrected for all future proposals.\n2.31(d)(1)\nINSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC).\nThe proposal CB-I-9246 involves collection of bone marrow specimens in pigs. Bone marrow was collected from\none animal on February 11, 2016. The Attending Veterinarian certified their involvement in the planning of the\nproposed activity on February 3, 2016. The IACUC members received the proposal and approved designated\nmember review on or about February 3, 2016. However, the Designated Member did not complete review and the\nproposal was not approved by the IACUC until February 26, 2016. Therefore, procedures were completed on one\nanimal prior to approval by the IACUC.\nThe IACUC must ensure that no proposed activities are initiated until after complete IACUC review and approval.\n\nInitiation of any procedure prior to approval precludes the IACUC from performing review and assurances under\n2.31 (d) such as related to minimization of pain or distress, consideration of alternatives, that activities do not\nunnecessarily duplicate previous experiments, the complete description of activities and the rationale for using\nanimals. Therefore,  lack of prospective review and approval precludes the IACUC members to fulfill their function of\nsafeguarding the welfare of the animals.\nThe IACUC must assure that no proposal-related activities occur prior to IACUC approval.\nCorrection date: From this date forward.\n2.31(e)(3)\nINSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC).\nThe proposal CB-I-9234 that involves guinea pigs states \u201cHistology is generally performed\u2026 biopsies\u2026 may be\ncollected by procedures from which the animals are allowed to recover. Other tissues will be removed under\nanesthesia as terminal procedures.\u201d However, under the Surgery section of the proposal it states \u201cSurgical\nProcedures \u2013 None\u201d and under \u201cSurgery\u201d it states \u201cNot Applicable.\u201d There is no description of the biopsy or terminal\nprocedures in the version of the proposal approved by the Institutional Animal Care and Use Committee (IACUC).\nThe proposal CB-I-9218 that involves pigs states \u201cBlood samples will be collected\u2026 via either surgically implanted\ncatheter or direct venipuncture.\u201d However, under the \u201cSurgery\u201d section of the proposal it states \u201cNot Applicable.\u201d\nThere is no description of the surgical implantation procedures in the version of the proposal approved by the\nInstitutional Animal Care and Use Committee (IACUC).\nThe IACUC must ensure that the investigator has provided a complete description of all procedures to be performed\non the animals. Without a complete description, the IACUC members are not able to consider possible alternatives\nthat might minimize pain and distress for the animals, to examine and ask questions about procedures and the\neffects on the animals. Therefore, such omission of these details precludes the IACUC members to fulfill their\nfunction of safeguarding the welfare of the animals.\nCorrection date: To be corrected in all approved proposals by 11/20/16 and from this date forward for new\nproposals.\n2.31(e)(4)\nINSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC).\nApproved proposal CB-I-9242 involving rabbits is a Category E study. The proposal form includes a section for\n\u201cOther potential stressors and procedures to monitor and minimize distress,\" and the investigator states: \u201cRabbits\nshowing indication of pain or distress may be administered any of the following as relevant: systemic analgesics\n\n(eg: buprenorphine); topical local anesthetics.\u201d Later in the \u201cJustification for Classification E\u201d section the investigator\nstates: \u201c\u2026 in most studies some toxicity will be intentionally produced and there may be attendant pain and/or\ndistress, and even mortality. In general it is assumed that pain-relieving drugs may interfere with the toxicity to be\nobserved, and such drugs are withheld.\u201d It is not clear whether there is any reason why these animals cannot\nreceive pain medications.\nCategory E studies are those where measures that would commonly be undertaken to minimize pain and distress,\nsuch as administering analgesics, cannot be undertaken because they would interfere with the goals of the study,\nand these studies must include a scientific justification. Without an explanation as to why pain medications cannot\nbe administered, the proposal should not be approved. \nCorrection date: The noncompliance cited above should be corrected for all future proposals.\nThis inspection and exit briefing were conducted with facility representatives.\nAdditional Inspectors\nSmith Pamela, Veterinary Medical Officer",
  "animals_total": 0,
  "species": [
    {
      "count": 0,
      "scientific": "NONE",
      "common": "NONE"
    }
  ]
}